NTRK1 genetic markers associated with progression of Alzheimer's Disease

Details for Australian Patent Application No. 2004293807 (hide)

Owner Genaissance Pharmaceuticals, Inc.

Inventors Dain, Bradley; Brain, Carlos; Ozdemir, Vural; Aerssens, Jeroen; Reed, Carol R.; Cohen, Nadine; Denton, R. Rex; Athanasiou, Maria; Judson, Richard S.

Agent Blake Dawson Waldron

Pub. Number AU-A-2004293807

PCT Pub. Number WO2005/052180

Priority 60/524,636 24.11.03 US

Filing date 22 November 2004

Wipo publication date 9 June 2005

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/052180 Priority application(s): WO2005/052180

29 November 2007 Assignment before Grant

  Genaissance Pharmaceuticals, Inc. The application has been assigned to PGxHealth, LLC

24 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293809-Apparatus and methods for assessing metabolic substrate utilization

2004293800-Flow sensor tube assembly and method for connecting a tube to a base member